A detailed history of First Command Financial Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, First Command Financial Services, Inc. holds 1,432 shares of LLY stock, worth $1.14 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,432
Previous 1,726 17.03%
Holding current value
$1.14 Million
Previous $592,000 13.34%
% of portfolio
0.06%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$350.74 - $468.98 $103,117 - $137,880
-294 Reduced 17.03%
1,432 $671,000
Q4 2022

Jan 20, 2023

BUY
$321.55 - $374.67 $5,466 - $6,369
17 Added 0.99%
1,726 $631,000
Q3 2022

Oct 24, 2022

BUY
$296.48 - $337.87 $19,271 - $21,961
65 Added 3.95%
1,709 $553,000
Q1 2022

Apr 14, 2022

SELL
$234.69 - $291.66 $20,418 - $25,374
-87 Reduced 5.03%
1,644 $471,000
Q4 2021

Jan 25, 2022

BUY
$224.85 - $279.04 $140,081 - $173,841
623 Added 56.23%
1,731 $478,000
Q3 2021

Jan 12, 2022

BUY
$221.6 - $272.71 $6,869 - $8,454
31 Added 2.88%
1,108 $256,000
Q2 2021

Jul 20, 2021

BUY
$180.55 - $233.54 $13,541 - $17,515
75 Added 7.49%
1,077 $247,000
Q1 2021

Apr 20, 2021

SELL
$164.32 - $212.72 $17,746 - $22,973
-108 Reduced 9.73%
1,002 $187,000
Q4 2020

Jan 19, 2021

BUY
$130.46 - $172.63 $9,914 - $13,119
76 Added 7.35%
1,110 $188,000
Q2 2019

Jul 15, 2019

BUY
$110.79 - $129.32 $22,158 - $25,864
200 Added 23.98%
1,034 $115,000
Q4 2018

Jan 24, 2019

BUY
$105.9 - $118.64 $88,320 - $98,945
834 New
834 $96,000
Q4 2018

Jan 24, 2019

SELL
$105.9 - $118.64 $67,246 - $75,336
-635 Closed
0 $0
Q2 2018

Jul 24, 2018

BUY
$75.7 - $86.88 $10,976 - $12,597
145 Added 29.59%
635 $54,000
Q1 2018

Apr 12, 2018

BUY
$74.21 - $87.6 $7,124 - $8,409
96 Added 24.37%
490 $38,000
Q3 2017

Oct 10, 2017

BUY
$77.07 - $85.54 $30,365 - $33,702
394
394 $34,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Command Financial Services, Inc. Portfolio

Follow First Command Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Financial Services, Inc. with notifications on news.